BioSpecifics Technologies Corp. Logo Image

BioSpecifics Technologies Corp.

Most Recent Annual Report

2019 Annual Report and Form 10K

BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. does not currently have any hardcopy reports on Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About BioSpecifics Technologies Corp.

1-10 Employees
Based in Lynbrook, New York

BioSpecifics Technologies Corp., a biopharmaceutical company, engages in the development of an injectable collagenase clostridium histolyticum for multiple indications in the United States. The company offers injectable collagenase for the treatment of Dupuytren’s contracture and Peyronie’s disease under the XIAFLEX brand in Canada, Australia, Brazil, and Mexico, as well as under XIAPEX brand name in Europe.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol